175 related articles for article (PubMed ID: 2441217)
21. [Clinical studies on interferon in cancer therapy in Japan].
Ohno R
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1194-202. PubMed ID: 2437862
[TBL] [Abstract][Full Text] [Related]
22. Interferon: a model for future biologicals.
Oldham RK
Interferon; 1985; 6():127-43. PubMed ID: 2410369
[No Abstract] [Full Text] [Related]
23. [Experimental research to clinical application of interferons].
Imamishi J; Tanaka A
Gan To Kagaku Ryoho; 1984 Jan; 11(1):53-9. PubMed ID: 6198966
[TBL] [Abstract][Full Text] [Related]
24. How interferons fight disease.
Johnson HM; Bazer FW; Szente BE; Jarpe MA
Sci Am; 1994 May; 270(5):68-75. PubMed ID: 8197446
[No Abstract] [Full Text] [Related]
25. [Interferons--biologic principles and clinical uses].
Jacobsen H; Kirchner H
Klin Padiatr; 1985; 197(4):263-7. PubMed ID: 3930830
[TBL] [Abstract][Full Text] [Related]
26. Biotherapy of chronic myelogenous leukemia with interferon.
Ozer H
Semin Oncol; 1988 Oct; 15(5 Suppl 5):14-20. PubMed ID: 2461592
[No Abstract] [Full Text] [Related]
27. Interferons and cancer: how the promise is being kept.
Borden EC
Interferon; 1983; 5():43-83. PubMed ID: 6202643
[No Abstract] [Full Text] [Related]
28. Phase I trials of biological response modifiers.
Smalley RV; Oldham RK
Drugs Exp Clin Res; 1986; 12(1-3):31-9. PubMed ID: 3089752
[TBL] [Abstract][Full Text] [Related]
29. [Therapeutic use of interferon: current trends and prospects].
Laghi V; Toccaceli F
Medicina (Firenze); 1990; 10(2):201-11. PubMed ID: 1703261
[No Abstract] [Full Text] [Related]
30. [Interferon in the treatment of viral hepatitis. The interferon was discovered 50 years ago].
Fehér J; Lengyel G
Orv Hetil; 2007 Aug; 148(33):1539-43. PubMed ID: 17686671
[TBL] [Abstract][Full Text] [Related]
31. Interferon treatment of human neoplasia.
Strander H
Adv Cancer Res; 1986; 46():1-265. PubMed ID: 2425561
[No Abstract] [Full Text] [Related]
32. Immunotherapy: the old and the new.
Oldham RK; Smalley RV
J Biol Response Mod; 1983; 2(1):1-37. PubMed ID: 6196449
[No Abstract] [Full Text] [Related]
33. Interferons as biochemical modulators.
Borden EC; Wadler S
J Clin Oncol; 1996 Oct; 14(10):2627-30. PubMed ID: 8874320
[No Abstract] [Full Text] [Related]
34. [Comparative study on the cytotoxic effects, on various human tumor cell lines, of recombinant human TNF and IFN (alpha, beta, gamma)].
Ogawara M; Sone S; Utsugi T; Nakanishi M; Ogura T
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):741-3. PubMed ID: 3103543
[No Abstract] [Full Text] [Related]
35. Interferons and cancer therapy.
Priestman TJ
J Pathol; 1983 Nov; 141(3):287-95. PubMed ID: 6363649
[TBL] [Abstract][Full Text] [Related]
36. [Current problems on interferon research].
Kishida T
Gan To Kagaku Ryoho; 1984 Jan; 11(1):10-5. PubMed ID: 6198963
[TBL] [Abstract][Full Text] [Related]
37. [The interferon system. A review of biological principles and clinical uses].
Schneider FJ
Z Gesamte Inn Med; 1986 Nov; 41(22):613-8. PubMed ID: 2436387
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of antiviral effect of type I, II, and III interferons on direct-acting antiviral-resistant hepatitis C virus.
Hamana A; Takahashi Y; Uchida T; Nishikawa M; Imamura M; Chayama K; Takakura Y
Antiviral Res; 2017 Oct; 146():130-138. PubMed ID: 28864074
[TBL] [Abstract][Full Text] [Related]
39. Additive and synergistic effects of a novel antiestrogen, toremifene (Fc-1157a), and human interferons on estrogen responsive MCF-7 cells in vitro.
Kangas L; Nieminen AL; Cantell K
Med Biol; 1985; 63(4):187-90. PubMed ID: 2419713
[TBL] [Abstract][Full Text] [Related]
40. Interferons in oncology: current status and future directions.
Smyth JF; Balkwill FR; Cavalli F; Kimchi A; Mattson K; Niederle NE; Spiegel RJ
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):887-9. PubMed ID: 2443361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
